[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370643-105":59,"doc-detail-370643-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploring-genes-associated-with-metabolic-dysfunction-as-therapeutic-targets-for-head-and-neck-cancers-a-novel-strategy","Exploring genes associated with metabolic dysfunction as therapeutic targets for head and neck cancers - a novel strategy","","Evidence suggests a potential link between metabolic dysfunction and head and neck cancer (HNC). This study investigates potential causal relationships between metabolic dysfunction and HNC using genetic data. While no significant causal associations were detected for metabolic indicators and HNC risk, gene inhibition showed risk reduction. Inhibiting SLC5A2 reduced risk for HNC and oropharyngeal cancer, and ATP-sensitive inward rectifier potassium channel 11 inhibition reduced oral cavity cancer risk. Inhibiting SLC5A1 and CACNB2-related genes linked to lower OPC risk.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-genes-associated-with-metabolic-dysfunction-as-therapeutic-targets-for-head-and-neck-cancers-a-novel-strategy/370643/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-genes-associated-with-metabolic-dysfunction-as-therapeutic-targets-for-head-and-neck-cancers-a-novel-strategy/370643.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research goal of this study?","Question",{"text":112,"@type":113},"To assess potential causal relationships between metabolic dysfunction and head and neck cancer using genetic data and to identify gene targets that could reduce cancer risk.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Did the study find significant causal links between metabolic indicators and HNC risk?",{"text":117,"@type":113},"No significant causal associations were identified between metabolic indicators and overall HNC risk.",{"name":119,"@type":110,"acceptedAnswer":120},"Which gene targets were associated with reduced cancer risk?",{"text":121,"@type":113},"Inhibiting SLC5A2 was linked to decreased risk of HNC and oropharyngeal cancer, while inhibiting ATP-sensitive inward rectifier potassium channel 11 reduced oral cavity cancer risk; SLC5A1 and a calcium channel subunit beta-2-related inhibition also related to lower OPC risk.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370643,1790218322,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Exploring genes associated with metabolic dysfunction as therapeutic targets for head and neck cancers: a novel strategy  \nSi-Yue Yin, MSca , Yu-Chen Liu, MDb , Yi-Pin Yang, MSca , Bing-Yu Liang, MScb , Zi-Yue Fu, MScb , Min Fan, MScb , Yu-Chen Zhang, MScb , Zi-Hui Xie, MScb , Ke Han, MScb , Jian-Peng Wang, BScb , Lei Zhang, MScb ,  \nLiang Zhang, MDb , Bu-Sheng Tong, MDb , Yan-Xun Han, MDb ,*, Cong-Jun Zhang, MDa ,*  \nAbstract  \nEvidence suggests a potential link between metabolic dysfunction and head and neck cancer (HNC) . This study investigates the potential causal relationships between metabolic dysfunction and HNC using genetic data. While no significant causal associations were identified between metabolic indicators and HNC risk, the research revealed that inhibition of certain genes could reduce cancer risk. Specifically, inhibiting sodium/glucose cotransporter 2 (SLC5A2) was associated with a decreased risk of HNC and oropharyngeal cancer (OPC), while ATP-sensitive inward rectifier potassium channel 11 inhibition was linked to a reduced risk of oral cavity cancer. Additionally, inhibiting SLC5A1 and voltage-dependent L-type calcium channel subunit beta-2 showed a connection to lower OPC risk. These findings suggest that targeting these genes could offer promising therapeutic strategies for preventing and treating HNC, as well as improving both preoperative and postoperative management in affected patients. Keywords: drug targets, head and neck cancer, Mendelian randomization, metabolic dysfunction  \nIntroduction  \nHead and neck cancer (HNC), comprising laryngeal cancer (LC), oral cavity cancer (OCC), and oropharyngeal cancer (OPC), poses significant challenges in early detection due to its concealed anatomical locations and the absence of reliable biomarkers for screening[1] . In 2024, the United States expects approximately 71 100 new HNC cases and 16 110 related deaths[2] . Limited surgical resources and treatment access complicates patient outcomes, highlighting the need for innovative therapies[3]. Despite the Cancer Genome Atlas providing extensive HNC genomic and  \naDepartment of Oncology and bDepartment of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital ofAnhui Medical University, Hefei, Anhui, China Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.  \nSi-Yue Yin, Yu-Chen Liu, Yi-Pin Yang, and Bing-Yu Liang contributed equally to this work and share first authorship.  \n*Corresponding authors. Address: Department of Oncology, The First Affiliated Hospital ofAnhui Medical University, 218 Jixi Road, Hefei, Anhui 230022, China. Tel: +86 13856019578. E-mail: ([zcj111zcj111@163.com](zcj111zcj111@163.com)) (C.J. Zhang); and Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, Anhui 230022, China.  \nTel.: +86 [18326655263. E-mail: 2246010181@stu.ahmu.edu.cn](18326655263. E-mail: 2246010181@stu.ahmu.edu.cn), [1423857841@qq.com](1423857841@qq.com) (Y.X. Han).  \nCopyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons AttributionNon Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. International Journal of Surgery (2025) 111:3129–3134  \nReceived 8 November 2024; Accepted 12 January 2025  \nSupplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s website, [www.lww.com/international-journal-of-surgery](www.lww.com/international-journal-of-surgery).  \nPublished online 5 February 2025  \n[http://dx.doi.org/10.1097/JS9.0000000000002293](http://dx.doi.org/10.1097/JS9.0000000000002293)  \nHIGHLIGHT","cbCait45gWnsDmQa","https://ap.wps.com/l/cbCait45gWnsDmQa","pdf",1994929,"English","# Abstract\n# Introduction\n# Study design and method\n# Findings and implications\n# Highlights","[{\"question\":\"What is the main research goal of this study?\",\"answer\":\"To assess potential causal relationships between metabolic dysfunction and head and neck cancer using genetic data and to identify gene targets that could reduce cancer risk.\"},{\"question\":\"Did the study find significant causal links between metabolic indicators and HNC risk?\",\"answer\":\"No significant causal associations were identified between metabolic indicators and overall HNC risk.\"},{\"question\":\"Which gene targets were associated with reduced cancer risk?\",\"answer\":\"Inhibiting SLC5A2 was linked to decreased risk of HNC and oropharyngeal cancer, while inhibiting ATP-sensitive inward rectifier potassium channel 11 reduced oral cavity cancer risk; SLC5A1 and a calcium channel subunit beta-2-related inhibition also related to lower OPC risk.\"}]","Exploring genes associated with metabolic dysfunction as therapeutic targets for head and neck cancers - a novel strategy | PDF",1790189606,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ec0dc70c78a0a22dcb5d0ad12a21c25.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55239135228dbd945d39ed5560be3695.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca020ae1ea6db0bda6f8d7abedb09b26.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5283568806cc2c72d407de4e90fbe159.webp",980,1306]